Underwriter Cantor Fitzgerald assists; deal funds corporate purposes
By Devika Patel
Knoxville, Tenn., Aug. 11 – Omeros Corp. said it priced a $40 million public offering of stock.
The company will sell the common shares at $11.50 per share. The price per share reflects a 10.65% discount to the Aug. 10 closing share price of $12.87.
Cantor Fitzgerald & Co. is the underwriter.
Settlement is expected Aug. 16.
Proceeds will be used for general corporate purposes, including research and development, clinical trials, pre-clinical studies, manufacturing development and other costs.
Omeros is a biopharmaceutical company based in Seattle.
| Issuer: | Omeros Corp.
|
| Issue: | Common stock
|
| Amount: | $40 million
|
| Price: | $11.50
|
| Warrants: | No
|
| Underwriter: | Cantor Fitzgerald & Co.
|
| Pricing date: | Aug. 11
|
| Settlement date: | Aug. 16
|
| Stock symbol: | Nasdaq: OMER
|
| Stock price: | $12.87 at close Aug. 10
|
| Market capitalization: | $428.01 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
